Filter
563
Text search:
laboratory
biosafety
Featured
Recommendations
92
New Publications
138
Language
Document type
No document type
289
Guidelines
128
Studies & Reports
55
Manuals
46
Strategic & Response Plan
24
Training Material
8
Situation Updates
5
Fact sheets
5
Resource Platforms
2
Brochures
1
Countries / Regions
India
33
Sierra Leone
21
Africa
18
Nigeria
17
Western and Central Europe
17
Latin America and the Carribbean
16
Ghana
12
Kenya
12
Rwanda
12
Liberia
11
Eastern Europe
11
Uganda
10
Brazil
10
Global
10
Ethiopia
8
West and Central Africa
8
Zambia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Congo, Democratic Republic of
6
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Nepal
5
South–East Asia Region
5
Russia
5
Guinea
4
Syria
4
Eastern Europe and Central Asia
4
Spain
4
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Namibia
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
202
Pharmacy & Technologies
52
Clinical Guidelines
46
Key Resources
22
Public Health
21
Women & Child Health
5
Capacity Building
1
Toolboxes
COVID-19
123
TB
102
Rapid Response
78
Ebola
60
AMR
37
HIV
14
Zika
11
NTDs
11
Conflict
9
Polio
8
Pharmacy
7
Caregiver
6
Planetary Health
6
Specific Hazards
4
Cholera
3
Natural Hazards
3
Health Financing Toolbox
2
Mental Health
1
Global Health Education
1
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited
...
A new respiratory infectious disease, COVID-19, caused by a new coronavirus called SARS-CoV-2, emerged in early December 2019. Since then, the virus has spread to India and 106 other countries in Asia, Europe, North America, Africa, and Oceania. On March 11, the World Health Organization (WHO) decl
...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers for Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceu
...
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien
...
Available in English, French, Spanish, Chinese, Russian and Arabic
https://apps.who.int/iris/handle/10665/337832
A Situational Assessment and Five-YearAction Plan for the Africa CDC Strengthening Regional Public Health Institutions and Capacity for Surveillance and Response Program
Despite the human and economic impact of viral epidemics, the world is not well enough prepared for the next emerging viral outbreak. Global trends indicate that new microbial threats will continue to emerge at an accelerating rate, driven by our growing population, expanded travel and trade network
...
This report contains the results of an in-depth Training Needs Assessment (TNA) of Health Workers in the 4 project counties of the republic of Kenya – Nakuru, Kisumu, Nairobi and Bungoma. The assessment, facilitated by the UPOPs Project in close collaboration with the Ministry of Health and Minist
...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus
...
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a
...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde
...
This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.
